Skip to main content
HealthReportedMediumDeveloping
4.8

Major drugmakers to halt clinical trials at certain China hospitals amid US House scrutiny

Major pharmaceutical companies have notified a U.S. House committee of plans to suspend clinical trials at select hospitals in China. The move follows heightened congressional scrutiny of trial integrity and data security risks. The scope of hospitals and companies affected remains unclear, but the shift signals a broader de-risking of China-based clinical operations.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

STAT Newsabout 17 hours agoUS, CNCredibility 19%View source

Score Breakdown

Mosaic Score4.8
Model confidence0.5
Significance0.5
Source credibility0.2

Intelligence Tags

Locations

China

Entities

United StatescountryChinacountry
Source

Related signals

8 found